Peter Pitts, a former associate commissioner of the FDA, joins "CUOMO" to discuss the resignation of Dr. Richard Pazdur, the ...

Rick Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...

So much for stability at the U.S. FDA. Three weeks after accepting the position as director of the FDA’s CDER, Richard Pazdur has informed the agency of his intention to retire at the end of the year.

A longtime FDA official who took over last month as the agency’s top drug regulator intends to retire.The departure of ...

Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating what’s already been a turbulent year at the FDA.

Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...

Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug ...

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...

Food and Drug Administration'‌s newly appointed head of the drug evaluation ‌department, Richard Pazdur, is set to retire ...

The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the agency just three ...